Get the Stockscreener App
0.1415
4.29%
-0.0055
BiomX Inc stock is traded at $0.1415, with a volume of 696.28K.
It is down -4.29% in the last 24 hours and down -29.65% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.147
Open:
$0.146
24h Volume:
696.28K
Relative Volume:
0.10
Market Cap:
$1.53M
Revenue:
-
Net Income/Loss:
$-47.68M
P/E Ratio:
-0.00567
EPS:
-24.9619
Net Cash Flow:
$-23.09M
1W Performance:
-14.73%
1M Performance:
-29.65%
6M Performance:
-97.62%
1Y Performance:
-98.67%
1-Day Range:
$0.14
$0.15
1-Week Range:
$0.14
$0.1639
52-Week Range:
$0.1192
$12.29
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.1422 | 1.59M | 0 | -47.68M | -23.09M | -24.96 |
VRTX
Vertex Pharmaceuticals Inc
|
515.90 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.46 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
992.29 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.97 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.63 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomX Company Profile & Introduction - Moomoo
BiomX Inc. SEC Filing (Aug 14, 2026) - Stock Titan
BiomX Inc. (PHGE): Nantahala reports 7.13% beneficial stake in 730,551 shares - Stock Titan
Biomx Inc (NYSE: PHGE) Share Price, PHGE Stock News, PHGE Share Price & Updates - kalkine.com.au
symbol__ Stock Quote Price and Forecast - cnn.com
BiomX Subsidiary Zorronet Receives Approximately $300,000 Purchase Order to Build Unified Operational Environment at Defense Technology Test and Evaluation Site - The Manila Times
BiomX Inc. (PHGE) investors disclose 0.7% stake and warrant holdings - Stock Titan
BiomX to acquire 10% stake in MEA Testing Systems, grants option for majority buyout - Investing.com
Form 8K Biomx Inc For: 11 August By Investing.com - Investing.com Nigeria
BiomX Buying 10% of MEA for $50,000 and 1.3M Shares; Option Through 2028 for Control - TradingView
Biomx Inc (PHGE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BiomX acquires 10% stake in electric motor testing firm By Investing.com - Investing.com Australia
BiomX Acquires 10% Stake in Motomea, Inventor of Advanced Electric Motor Technologies for Drone and Autonomous Systems - The Manila Times
Exclusive License Lets BiomX Develop and Distribute Drone Testing Solutions - Stock Titan
BiomX amends Zorronet acquisition note, to issue shares By Investing.com - Investing.com Nigeria
BiomX Amends $1.25M Note With Water IO; Extends to Nov. 1 and Issues 800,000 Shares - TradingView
BiomX Amends Zorronet Acquisition Promissory Note, Extends Water.IO Payment Schedule - Quiver Quantitative
BiomX And Water.IO Agree To Updated Zorronet Acquisition Terms - marketscreener.com
BiomXMay Offer And Sell Up To $9.10 Million Of Common Stock Through WainwrightSEC Filing - TradingView
Biomx Inc (PHGE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biomx Inc (PHGE) Cash Flow - TradingKey
BiomX Inc. (PHGE) Edges Higher on Light Trading: Support Holds at $0.18Liquidity Sweep - dars.gov.et
Biomx Inc (PHGE) Balance Sheet - TradingKey
TradingKey - TradingKey
Biomx Inc (PHGE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PHGE|Biomx Inc|Price:0.189|Chg%:-0.011 - TradingKey
Biomx Inc (PHGE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Biomx Inc (PHGE) Institutional Confidence - TradingKey
Biomx Inc (PHGE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biomx Inc (PHGE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Biomx Inc (PHGE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
PHGE|Biomx Inc|Price:0.181|Chg%:-0.008 - TradingKey
BiomX Inc. (PHGE) Declines 4.69% as Stock Nears Critical Support at $0.18ETF Creation Redemption - dars.gov.et
BiomX Inc. (PHGE) Stock Price, News, Quote & History - Yahoo! Finance Canada
BiomX's Zorronet expands in Europe with AI coll... - Pluang
BiomX Subsidiary Zorronet Expands European Presence Through Two Strategic Collaborations in Europe - The Manila Times
BiomX Subsidiary Zorronet Enters Strategic Collaboration with Samura s.r.o. for AI-Powered Monitoring Solutions in Europe - Quiver Quantitative
BiomX (PHGE) Proxy filing Summary - Quartr
BiomX (PHGE) Stock Forum and Discussion - Moomoo
BiomX (PHGE) Analyst Ratings, Stock Forecast and Price Target - Moomoo
Form PRE 14A BIOMX INC. For: 17 July By Investing.com - Investing.com Nigeria
BiomX Inc. (PHGE) Q4 2025 Earnings: Wider-than-Expected Loss Sends Shares LowerCapex Guidance - dars.gov.et
BiomX Inc. (PHGE) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
BiomX Inc. (NYSE: PHGE) seeks approval for Mandragola securities, $2M credit line and reverse split - Stock Titan
BiomX (PHGE) stock soars over 25% after-hours: Here's why it is trending - MSN
BiomX (PHGE) Continues to Test Support at $0.20 Amid Modest DeclineAI Trade Signals - dars.gov.et
BiomX(PHGE) Stock Options Chain | Quotes & News - Moomoo
[EFFECT] BiomX Inc. SEC Filing - Stock Titan
BiomX Inc. (PHGE) Holds Steady Near Support: A Quiet Session for the Micro-Cap Biotech StockLiquidity Sweep - dars.gov.et
BiomX signs LOI to acquire 60% of Israeli systems integrator Tsoock for $10.4M - MSN
BiomX Cancels Conversion Shares to Restore NYSE Compliance - The Globe and Mail
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):